Because B anthracis (anthrax) has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are infected and untreated, the American Academy of Pediatrics (AAP) offers clinical guidance that can be quickly implemented when needed.
Pediatric Anthrax Clinical Management and an Executive Summary, were published in Pediatrics in May 2014.
- Red Book™ Online - Infectious Diseases: Anthrax
- Agency Approaches to Validation and Statistical Analyses Could Be Improved (GAO)
- Report from AAP, CDC offers guidance on managing children after anthrax attack (AAP)
- Conference Report on Public Health and Clinical Guidelines for Anthrax (CDC)
- Ethics of Administering Anthrax Vaccine to Children - Pages 125-129 (Public Health Ethics: Cases Spanning the Globe)
- Summary of Recommendations From the 2003 National Consensus Conference on Pediatric Preparedness for Disasters and Terrorism chaired by Drs David Markenson and Irwin Redlener
- Use of Anthrax Vaccine in the United States (CDC)
American Academy of Pediatrics